The suspected pollution of Erkang Pharmaceuticals' Cambodian factory was evicted due to a local request and an announcement will be made later
Serious pollution
Ligand Pharmaceuticals Collaborates With China Resources Double-Crane to Develop Oral COVID-19 Therapeutic
10:33 AM EDT, 10/21/2021 (MT Newswires) -- Ligand Pharmaceuticals (LGND) said Thursday it has granted exclusive Asia territorial rights to China Resources Double-Crane Pharmaceutical to develop an ex
Ligand Pharmaceuticals and China Resources Double-Crane ink collaboration agreement
Ligand Pharmaceuticals (NASDAQ:LGND) has signed a collaboration agreement granting China Resources Double-Crane Pharmaceutical exclusive Asia territorial rights to develop a novel investigational ora
On September 16, six companies announced positive results: Angel Yeast plans to establish a joint venture with Neubao Foods to develop the baby snack food business
Yutong Technology announced that it plans to spend 100 million to 200 million yuan to repurchase shares of Yutong Technology. The company plans to repurchase the company's shares at a price of no more than 41.19 yuan/share, with a repurchase amount of not less than 10 million yuan and no more than 20 million yuan. All of the shares repurchased will be used for employee stock ownership plans or equity incentive plans. Angel Yeast announced that it plans to establish a joint venture with Neubao Foods to develop the baby snack food business Angel Yeast. In order to promote the rapid development of the baby snack food business segment, Angel Yeast plans to establish a joint venture with Kang Helong, Hubei Neubao Food Technology Co., Ltd. (with industry and commerce)
On September 15, 10 companies including Angel Yeast and Yan'an Bikang announced favorable results
1. Angel Yeast: Angel Yeast announced that it intends to establish a joint venture with Kang Helong to develop the baby snack food business. In order to promote the rapid development of the baby snack food business segment, Angel News plans to establish a joint venture with Kang Helong. The joint venture will seek new opportunities for development in the field of infant snack food as a holding subsidiary specializing in the development of products related to the snack food industry by Angel Newt. 2. Poinsettia: The wholly-owned subsidiary obtained the bromhexine hydrochloride injection registration certificate. The wholly-owned subsidiary obtained the bromhexine hydrochloride injection registration certificate. 3. Qianjing Garden: Won the bid 67
Analysis of Suyan Jingshen's daily limit on September 13th: soda ash, longevity drug NMN, state-owned enterprise reform concept hot stock
Securities Star data Center News, Su Yanjing God rose to close, closing price 10.59 yuan. The stock rose by the daily limit at 13:27, but did not open the limit. The closing capital was 40.653 million yuan, accounting for 0.69% of its current market value. In terms of capital flow data, the net inflow of main funds on the same day was 74.5619 million yuan, the net inflow of hot capital was 59.3568 million yuan, and the net outflow of retail funds was 45.3595 million yuan. In the past 5 days, the capital flow is shown in the following table: the stock is soda ash, longevity drug NMN, state-owned enterprise reform concept hot stock, the same day soda ash concept rose 4.51%, longevity drug NMN concept rose 1.
Analysis of Suyan Jingshen's daily limit on September 8th: soda ash, Jiangsu state-owned enterprise reform, longevity drug NMN concept hot stock
Securities Star data Center News, Su Yanjing God rose to close, closing price 9.98 yuan. The stock rose by the daily limit at 09:57 and opened once, with a closing fund of 44.8553 million yuan, accounting for 0.8 per cent of its current market value. In terms of capital flow data, the net inflow of main funds on the same day was 47.5186 million yuan, the net inflow of hot capital was 45.9349 million yuan, and the net outflow of retail funds was 27.5071 million yuan. In the past 5 days, the capital flow is shown in the following table: this stock is soda ash, Jiangsu state-owned enterprise reform, longevity drug NMN concept hot stock, the same day soda ash concept rose 5.02%, Jiangsu state-owned enterprise reform concept rose 3.
Suyan Jingshen: plan to invest 2.231 billion yuan to build the first phase of Chuzhou Zhangxing Gas Storage Project, the god of Jiangsu salt industry.
On August 26th, Capital State learned that Suyan Jingshen (603299.SH), an A-share company, invested in the construction of the first phase of Zhangxing gas storage in Chuzhou, the salt well god of Jiangsu Province. In order to actively respond to the call of the CPC Central Committee and the State Council to speed up the construction of natural gas production, supply, storage and marketing system, as well as a series of requirements of Jiangsu Province to speed up the construction of natural gas reserve capacity, implement the 14th five-year Plan for Jiangsu National Economic and Social Development and the outline of the long-term objectives for the year 2035, the 14th five-year Plan for the Development of Oil and Gas in Jiangsu Province and the Strategic Development Plan of Suyan Jingshen Promote the high-quality development of the company to be in the forefront of the industry.
On July 29th, four companies announced negative results: Jintong Anyi, a data shareholder of Synergy, intends to reduce its stake by no more than 4.58%.
Jiechuang data shareholder Jintong Anyi plans to reduce its stake of no more than 4.58% of the company's total share capital. Anhui High-tech Jintong Anyi Phase II Venture Capital Fund (Limited Partnership), which holds 9451796 shares (accounting for 4.58% of the company's total share capital), plans to reduce its holdings of the company's shares by competitive or block trading within six months, a total of no more than 9451796 shares (that is, a total of not more than 4.58% of the company's total share capital). Jubilee Technology: the company is in the state of no controlling shareholder and actual controller. Jubilee Technology announcement, the company recently received more than 5% of the company's original shareholder Ruichen Investment and its concerted actor Tan Song.
Al ophthalmology fell by more than 9%! It is proposed to raise 3.6 billion yuan, more than the total amount raised since listing.
On July 6, Ayre's ophthalmology fell sharply in intraday trading. As of press time, El Ophthalmology quoted price of 62.27 yuan per share, a decline of 9.45%. On the news, Ayre Ophthalmology announced on July 5 that it plans to issue shares to no more than 35 specific investors, raising no more than 3.65 billion yuan. At present, the list of additional targets has not been disclosed. According to the data of shareholder reduction, Ayre Ophthalmology is the largest ophthalmic medical chain in China, and it is also a Daniel stock with a market capitalization of more than 300 billion. In recent years, Ayre Ophthalmology, as a leading ophthalmology company, has been popular in the capital market, and the company's share price has risen tenfold since 2017. And at 7.